• Everolimus-induced pneumonitis associates with favourable outcome in patients with metastatic renal cell carcinoma.

    Mammalian target of rapamycin inhibitors may induce pneumonitis. We analysed the association of pneumonitis with outcomes in everolimus treated metastatic renal cell carcinoma (mRCC) patients.

    Eighty-five mRCC patients received everolimus at Helsinki University Hospital (cohort A).

    Published June 9, 2017
  • Pulmonary manifestations of urothelial carcinoma of the bladder.

    Urothelial carcinoma (Transitional cell carcinoma) of the bladder is the pre-dominant histological type of bladder cancer in the United States and Europe. Patients with bladder cancer usually present with painless hematuria.

    Published June 23, 2017
  • Supportive care for patients undergoing immunotherapy.

    Immune checkpoint inhibitors, a new class of cancer therapeutic agents, play an important role in the management of melanoma, NSCLC, and other malignancies. A workshop organized by three MASCC Study Groups: Oral Care, Skin Toxicities, and Neutropenia, Infection, and Myelosuppression during the MASCC Annual Meeting held in Adelaide, Australia on 23-25 June, 2016 focused on the new class of anti-cancer therapeutic agents.

    Published July 17, 2017